Rhumbline Advisers »

Aslan Pharmaceuticals Lt shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Aslan Pharmaceuticals Lt shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Aslan Pharmaceuticals Lt

Tip: Access up to 7 years of quarterly data

All positions including Aslan Pharmaceuticals Lt held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aslan Pharmaceuticals Lt by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $16 29 0.59
2025-12-31 $16 29 0.59
2025-09-30 $16 29 0.59
2025-06-30 $60 101 0.59
2025-03-31 $95 160 0.59
2024-12-31 $95 160 0.59
2024-09-30 $95 160 0.59

Top funds holding Aslan Pharmaceuticals Lt